Questions and Answers on the Propofol Shortage

Questions and Answers on the Propofol Shortage
The U.S. Food and Drug Administration (FDA) is aware that recent shortages of propofol injection—a quick acting sedative-hypnotic used for the induction and maintenance of anesthesia or sedation—have resulted in significant concerns for some healthcare professionals in regard to patient care. The Agency has made every effort within its legal authority to address this problem. FDA has temporarily allowed the importation of Fresenius Propoven 1% into the United States. This propofol product is comparable to the product used in the United States and is currently approved in other countries. FDA is also working with the manufacturers of propofol products to try to prevent future shortages.

open here to see the full-text:
Questions and Answers on the Propofol Shortage